Trial Profile
Exploratory study of FYX-051 in Patients with Hyperuricemia (with or without Gout)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2017
Price :
$35
*
At a glance
- Drugs Topiroxostat (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Fuji Yakuhin
- 02 Jun 2016 New trial record